1'756 companies found
adastra AG
Pfäffikon Sz · Since 2004
ADD Advanced Drug Delivery Technologies Ltd
Pratteln · Since 1998
The core activity of ingredientpharm is the development and marketing of niche pharmaceutical excipients, particularly for solid dosage forms, with a strong focus on controlled release and taste masking. The company also offers solutions for the development and production of pharmaceutical and cosmetic products, including the supply of active ingredients, excipients and services such as the development of customized formulations and the production of samples.
Addex Pharma SA
Plan-Les-Ouates · Since 2002
Addex Pharma SA is a clinical-stage pharmaceutical company focused on the development and commercialization of orally available small-molecule allosteric modulators for neurological disorders. Its pipeline includes programs such as dipraglurant (mGlu5 NAM), ADX71149 (mGlu2 PAM) and GABAB PAM candidates targeting indications including substance use disorder and chronic cough.
ADEXILIS Schweiz AG
Wilen (Sarnen) · Since 2010
The core activity of ADEXILIS is the regional representation of life science companies, biopartnering and the development of its own products and concepts, particularly through the integrated DiamondLily concept. The company is active in various European countries and focuses on representing companies that offer innovative products and technologies in the life sciences sector.
ADIENNE Pharma & Biotech SA
Lugano · Since 2013
ADIENNE Pharma & Biotech SA is an integrated biopharmaceutical group that develops medicinal products and provides pharmaceutical and biotech manufacturing services. The company focuses on rare hematological and immunological diseases, maintains a portfolio of orphan-designated, marketed, clinical and preclinical product candidates, offers lyophilization for cytotoxic products in ready-to-use systems, and its lead clinical candidate is BEGELOMAB.
ADIENNE SA
Lugano · Since 2012
ADIENNE SA is an integrated biopharmaceutical group focused on research, development and manufacturing of medicines for rare and severe hematological and immunological diseases. The company provides GMP development and manufacturing services, including lyophilization of cytotoxic finished products in ready-to-use systems (e.g., Multichamber Flexible Bag, FillChoice), and markets products such as TEPADINA® and PHELINUN®.
Adler Pharma Helvetia AG
Sarnen · Since 2009
The core activity of Adler Pharma is the development, manufacture and distribution of products based on Schüssler salts, particularly in the areas of health care, disease prevention and personal responsibility for one's own life. This also includes cosmetic products and other means of supporting health.
Adoram Therapeutics SA
Grand-Lancy · Since 2022
The core activity of Adoram Therapeutics is the development of innovative small molecules as immunotherapeutics for the treatment of solid tumors and immune-based diseases. To this end, the company leverages the benefits of allosteric biochemistry, in particular the development of allosteric modulators for adenosine receptors, to create new treatment options.
ADVANCED ACCELERATOR APPLICATIONS INTERNATIONAL SA
Geneva · Since 2014
The core activity of Advanced Accelerator Applications (AAA) is the development and delivery of products and services in the field of nuclear medicine, particularly in the areas of radioligand therapy (RLT) and molecular imaging with positron emission tomography (PET).
Advanced Microbiotics AG
Zug · Since 2024
The core activity of Advanced Microbiotics AG is the research, development, production and marketing of highly effective microorganisms for medical applications, particularly in the manufacture of probiotic products for health maintenance, health improvement and the treatment of various diseases.
Advanz Pharma Specialty Medicine Switzerland GmbH
Zurich · Since 2015
Advitech Consulting SA
Lugano · Since 2024
Advitech Consulting SA is a boutique advisory firm focused on the healthcare and fine chemical industries, providing corporate business development, management consulting and business intelligence services, and product & technologies portfolio management.
AESKULAP International AG
Lucerne · Since 2010
The core activity of Aeskulap-International includes research and development, medical education, and the manufacture of high-quality medical products and dietary supplements, particularly in the field of cancer treatment and prevention. This also includes medical consulting services, medical tourism, and the production of products for organ therapy and stem cell transplantation.
Ageronix SA
Carouge Ge · Since 2013
Ageronix's core activity is the development of treatments for neurodegenerative diseases, particularly using the protein Alpha 1 Anti-Trypsin (AAT). The company focuses on researching and developing therapies for rare neurological disorders, such as Charcot-Marie-Tooth disease (CMT), and has already completed preclinical developments and plans to initiate clinical trials in 2024.
AKROSWISS AG
Zug · Since 2006
The core activity of Akroswiss is the development and marketing of innovative nasal treatments for central nervous system (CNS) diseases, particularly for epileptic seizures and anxiety disorders (claustrophobia) during MRI examinations. The company focuses on developing minimally invasive, intranasal drug formulations with a unique 360° function for rapid and effective administration.
Alexion Pharma GmbH
Baar · Since 2007
The core activity of Alexion is the development and provision of life-changing therapies for people with rare diseases. The company focuses on researching, developing and delivering medicines tailored to the needs of patients with rare diseases, and strives to improve the quality of life of these individuals.
ALK-Abelló AG
Wallisellen · Since 1990
The core activity of the company ALK is the development, manufacture and marketing of products for specific immunotherapy, in particular for the prevention, diagnosis and treatment of allergies, including allergic rhinitis and allergic asthma.
Allergopharma AG
Hünenberg · Since 1973
The core activity of Allergopharma AG is the diagnosis and treatment of Type I allergies, particularly through subcutaneous immunotherapy (SCIT) and the development of high-dose, hypoallergenic preparations (allergoids) as well as allergens for diagnostic purposes.
AllergyCare AG
Schaffhausen · Since 2005
AllergyCare AG sells medical and care products for the prevention and management of allergies, skin conditions, respiratory problems and gastrointestinal complaints. The product range includes DermaSilk garments and bedding, mite-proof Microair covers and masks, probiotic products such as BiGaia and supplements like Osfortis; the website indicates that product effectiveness is clinically tested.
Almeda Pharmaceuticals AG
Zug · Since 2023
The core activity of Almeda Pharmaceuticals AG is the development, manufacture and marketing of pharmaceutical products, in particular specialized medicines, generics and dietary supplements. The company focuses on the areas of oncology, transplantation medicine, CNS diseases, antimicrobial therapies, rare diseases and nutrition supplements. Almeda Pharmaceuticals AG positions itself as a reliable partner for the distribution and marketing of medicines in the CIS region (Commonwealth of Independent States) and other selected geographical regions.
Outbound Leads by COHAGALeadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubHow the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register